Brind.

KALA BIO, Inc. appointed Todd Bazemore as CEO and confirmed the CHASE trial is Phase 2b, leveraging the MSC-S platform.

1 report, 1 independent Updated Sep 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

KALA BIO, Inc.MSC

Keep exploring

The entities involved

KALA BIO, Inc.
Czech company
- Ashley Weaver, representing the Kentucky FFA Foundation, was involved in an event where Fords established an agriculture department.Wed 22:32
MSC
Nothing else this week.

Coverage

Newest first; wire copies grouped

Sep 2GlobeNewswireKALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director Mr. Bazemore brings over 30 years of extensive leadership experience in the biopharmaceutical industry with a focus